Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Peter Nash; Iain B McInnes; Philip J Mease; Howard Thom; Matthias Hunger; Andreas Karabis; Kunal Gandhi; Shephard Mpofu; Steffen M Jugl

doi:10.1007/s40744-018-0117-3

Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Peter Nash, Iain B McInnes, Philip J Mease, Howard Thom, Matthias Hunger, Andreas Karabis, Kunal Gandhi, Shephard Mpofu, Steffen M Jugl

Research output: Contribution to journal › Comment/debate (Academic Journal) › peer-review

242 Downloads (Pure)

Abstract

Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was published incorrectly in a sentence. The correct sentence should read as follows.

Original language	English
Number of pages	1
Journal	Rheumatology and Therapy
Early online date	1 Jun 2018
DOIs	https://doi.org/10.1007/s40744-018-0117-3
Publication status	E-pub ahead of print - 1 Jun 2018

Access to Document

10.1007/s40744-018-0117-3

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Springer at https://link.springer.com/article/10.1007%2Fs40744-018-0117-3 . Please refer to any applicable terms of use of the publisher.
Final published version, 338 KBLicence: CC BY

Handle.net

Persistent link

1 Article (Academic Journal)

Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
Nash, P., McInnes, I. B., Mease, P. J., Thom, H., Hunger, M., Karabis, A., Gandhi, K., Mpofu, S. & Jugl, S. M., Jun 2018, In: Rheumatology and Therapy. 5, 1, p. 99-122 24 p.
Research output: Contribution to journal › Article (Academic Journal) › peer-review

Open Access
File
41 Citations (Scopus)

334 Downloads (Pure)

Cite this

Nash, P., McInnes, I. B., Mease, P. J., Thom, H., Hunger, M., Karabis, A., Gandhi, K., Mpofu, S., & Jugl, S. M. (2018). Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison. Rheumatology and Therapy. Advance online publication. https://doi.org/10.1007/s40744-018-0117-3

@article{5d182b24d53e4555b2c52f6f73b742a1,

title = "Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison",

abstract = "Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was published incorrectly in a sentence. The correct sentence should read as follows.",

author = "Peter Nash and McInnes, \{Iain B\} and Mease, \{Philip J\} and Howard Thom and Matthias Hunger and Andreas Karabis and Kunal Gandhi and Shephard Mpofu and Jugl, \{Steffen M\}",

year = "2018",

month = jun,

day = "1",

doi = "10.1007/s40744-018-0117-3",

language = "English",

journal = "Rheumatology and Therapy",

issn = "2198-6576",

publisher = "Adis",

}

TY - JOUR

T1 - Correction to

T2 - Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

AU - Nash, Peter

AU - McInnes, Iain B

AU - Mease, Philip J

AU - Thom, Howard

AU - Hunger, Matthias

AU - Karabis, Andreas

AU - Gandhi, Kunal

AU - Mpofu, Shephard

AU - Jugl, Steffen M

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was published incorrectly in a sentence. The correct sentence should read as follows.

AB - Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was published incorrectly in a sentence. The correct sentence should read as follows.

U2 - 10.1007/s40744-018-0117-3

DO - 10.1007/s40744-018-0117-3

M3 - Comment/debate (Academic Journal)

C2 - 29858770

SN - 2198-6576

JO - Rheumatology and Therapy

JF - Rheumatology and Therapy

ER -

Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Abstract

Access to Document

Handle.net

Fingerprint

Research output

Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

Cite this